Key Points

Dr Jitendra Singh highlighted India's transformative potential in preventive healthcare during a critical meeting on cervical cancer screening. The discussion emphasized India's remarkable progress in developing indigenous medical technologies like HPV test kits and DNA vaccines. By showcasing innovative research and strategic public-private partnerships, India is repositioning itself as a global leader in medical solutions. These advancements not only address significant health challenges but also restore international respect for Indian scientific capabilities.

Key Points: Dr Jitendra Singh Spotlights India's Preventive Healthcare Breakthrough

  • India ranks fourth globally in cervical cancer morbidity
  • Indigenous HPV test kits mark significant healthcare milestone
  • First DNA vaccine puts India on global medical research map
  • Breakthrough gene therapy trials recognized internationally
2 min read

Time to position India as global leader in preventive healthcare: Dr Jitendra Singh

Union Minister reveals India's pivotal role in cervical cancer screening and innovative healthcare solutions targeting global health challenges

"The DNA vaccine has projected India as a country capable of leading in preventive healthcare - Dr Jitendra Singh"

New Delhi, April 23

With 25 per cent of global cervical cancer deaths occurring in India -- often due to late diagnosis -- there is a critical need for preventive screening strategies, Union Minister Dr Jitendra Singh said on Wednesday, adding that the ultimate goal is to position India as a global leader in preventive healthcare.

Dr Singh convened a joint meeting of Department of Biotechnology (DBT), AIIMS New Delhi, BIRAC, ICMR and industry partners here to review the indigenously developed HPV test kits for cervical cancer screening in India and described it as another milestone in preventive healthcare achieved by the DBT, under the Ministry of Science and Technology.

He drew attention to India ranking fourth globally in cervical cancer-related morbidity, underscoring the urgent need for action. He cautioned, however, that HPV is not the sole cause of cervical cancer, but studies have shown a 90 per cent correlation, supporting the case for targeted prevention.

The minister said that the ultimate objective is to enable affordable, accessible, and ideally mass screening for cervical cancer.

The minister said it is now the right time to acknowledge a series of significant milestones accomplished by the team at DBT and BIRAC, including the development of the first-ever DNA vaccine, which brought India international recognition and restored esteem to Indian science in the field of healthcare.

"The DNA vaccine has projected India as a country capable of leading in preventive healthcare -- a stark contrast to the outdated perception that India neither prioritized preventive, nor even curative healthcare," said Dr Singh.

He also referred to Nafithromycin, India's first indigenous antibiotic, which has received encouraging feedback.

Dr Singh reiterated that the involvement of the private sector is integral to these success stories, highlighting a "whole-of-science and whole-of-government approach."

Another breakthrough cited was the successful gene therapy trial in hemophilia, which earned a spot in the prestigious New England Journal of Medicine (NEJM). Notably, both the British Medical Journal and NEJM, among the world's oldest medical journals, have acknowledged India's pioneering healthcare research.

The minister coined the term "PPP plus PPP", referring to Public-Private Partnerships both within and beyond national borders, a model successfully adopted by several European nations, particularly in life sciences and healthcare.

- IANS

Share this article:

Reader Comments

P
Priya K.
This is such an important initiative! My aunt was diagnosed with cervical cancer too late. Preventive screening could save so many lives. Proud to see India taking leadership in healthcare innovation 👏
R
Rahul S.
While I appreciate the focus on preventive healthcare, I hope the government ensures these screening programs reach rural areas too. Urban centers usually get these benefits first while rural women need them just as much.
A
Ananya M.
The DNA vaccine development is incredible! India's scientific community deserves more recognition. Maybe this will inspire more young people to pursue careers in medical research 💉
V
Vikram P.
Public-private partnerships sound promising, but I hope there's strict oversight to keep healthcare affordable. We don't want corporate interests making these screenings inaccessible to the poor.
S
Sunita R.
As a nurse, I've seen firsthand how early detection changes outcomes. This initiative gives me hope! The HPV test kits could be game-changers if implemented properly across all states.
K
Karan J.
The article mentions international recognition - that's great, but let's not forget we need to fix basic healthcare infrastructure too. Preventive care is important, but so is having enough hospitals and doctors.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50